The following terms and phrases were searched from the above-mentioned electronic databases:

Dual therapy vs triple therapy and atrial fibrillation;

NOAC and atrial fibrillation and percutaneous coronary intervention;

Oral anticoagulant and atrial fibrillation and coronary stenting;

Dual vs triple therapy and AF and percutaneous coronary intervention;

Dual vs triple therapy and AF and diabetes mellitus and percutaneous coronary intervention;

NOAC and atrial fibrillation and diabetes mellitus and percutaneous coronary intervention;

Warfarin and percutaneous coronary intervention.

Respective names of the NOAC were also used during the search process:

Dabigatran and atrial fibrillation and percutaneous coronary intervention;

Rivaroxaban and atrial fibrillation and percutaneous coronary intervention;

Apixaban and atrial fibrillation and percutaneous coronary intervention;

Endoxaban and atrial fibrillation and percutaneous coronary intervention.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.